Proteomics Market Projected to Reach USD 128 Billion by 2032

1
Proteomics Market Projected to Reach USD 128
Billion by 2032
2

• Industry Insights

• The global proteomics market value is projected
  to rise substantially over 2023-2032, owing to
  the development of technologically advanced
  instruments including 2D electrophoresis protein
  analysers.
• The integration of engineered devices such as
  biochips can improve the throughput and
  efficiency of biological research, workflow, and
  speed. Such tech innovations, along with the
  mounting investment in protein engineering
  facility expansion projects, are expected to
  boost proteomics analysis.
• Citing an instance, in February 2022, the NIH's
  National Institute of General Medical Sciences
  announced funding to establish a Genetic Code
  Expansion Center in Oregon. This facility was
  intended to revolutionize protein-focused
  biomedical and material research and solidify the
  state's status as a leader in the advancement of
  protein engineering. Initiatives such as these
  are likely to increase the reliance on engineered
  proteins for selective proteomics research
  applications.
• The proteomics industry is categorized in terms
  of component, technique, application, end-use,
  and regional landscape.

3

• In addition, proteomics facilities are equipped
  with state-of-the-art equipment and
  bioinformatics tools for data evaluation and
  interpretation. Such factors are anticipated to
  proliferate the advancement of proteomics
  technologies.
• Proteomics market size from the conventional
  technique segment is slated to rise by 2032. This
  is on account of innovations in liquid
  chromatography that allow efficient analysis of
  proteomes of single cells. Several lab instrument
  manufacturing companies are also focused on
  launching chromatography solutions to support
  life science research, driving the adoption of
  clinical proteomics.
• Based on the application, the industry share from
  the clinical diagnosis segment is poised to
  depict a strong growth rate through 2032, due to
  the surge in vaccine-preventable disease
  outbreaks. As per the WHO, in Africa, over 17,500
  cases of measles were reported between January
  and March 2022, indicating a 400 rise from a
  year earlier. This growing disease burden is
  likely to increase the reliance on proteomics to
  discover biomarkers that indicate a particular
  disease.
• Global proteomics industry value from the other
  end-use segment, including hospitals and research
  organizations, is projected to be worth more than
  USD 7.5 billion by 2032, owing to the increase in
  healthcare research funding.

4

• Regional Analysis

On the regional front, North America accounted
for more than 47.5 share of the proteomics
market in 2022, given the strong presence of key
players and constant government support for
proteomics research. Asia Pacific proteomics
industry size is also anticipated to witness an
upsurge by 2032, considering the introduction of
novel drug discovery projects for chronic
diseases and the development of innovative mass
spectrometers.

• Competitive Analysis

• Olink
• Biognosys AG
• Agilent Technologies, Inc
• Creative Proteomics
• Thermo Fisher Scientific
• SomaLogic Operating Co
• Promega Corporation
• Bio-Rad Laboratories
• Proteomics GmBH

5
Biotechnology Instruments Market _at_
https//www.gminsights.com/industry-analysis/prote
omics-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/5
391
Request for customization _at_ https//www.gminsights
.com/roc/5391
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com